Citation Impact
Citing Papers
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
2009
Differing Phenotypes between Intraepithelial and Stromal Lymphocytes in Early-Stage Tongue Cancer
2007
Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells
2011
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
2011
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
The Prevalence of FOXP3 + Regulatory T-Cells in Peripheral Blood of Patients with NSCLC
2009
Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review
2014
Lactate in human sweat: a critical review of research to the present day
2012
Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer
2007
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
2015
Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
2014
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
2008
The role of laser microsurgery in the treatment of laryngeal cancer
2007
Base-excision repair of oxidative DNA damage
2007 StandoutNature
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer
2003
Pancreatic cancer
2004 Standout
A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients
2010
Induced and natural regulatory T cells in human cancer
2012
Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses
2019
Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis
2016 StandoutNature
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Telomerase inhibition and the future management of head-and-neck cancer
2002
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
2007
Substrate specificities and excision kinetics of DNA glycosylases involved in base-excision repair of oxidative DNA damage
2003
Regulatory T Cells in Cancer
2010
Head and neck cancer
2008 Standout
Current concepts and new horizons in conservation laryngeal surgery: An important part of multidisciplinary care
2009
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
The Human T Cell Response to Melanoma Antigens
2006
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Indoleamine 2,3‐dioxygenase in T‐cell tolerance and tumoral immune escape
2008
Tumor Infiltrating T Lymphocytes in Colorectal Cancer
2006
Transoral robotic surgery of the oropharynx: Clinical and anatomic considerations
2011
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Genetic susceptibility–molecular epidemiology of head and neck cancer
2002
An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
2010
Definitive Radiotherapy for Tonsillar Squamous Cell Carcinoma
2006
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twice-daily treatment?
2003
Management of T1–T2 glottic carcinomas
2004
C → T mutagenesis and γ‐radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases
2005 StandoutNobel
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
FOXP3 and survival in urinary bladder cancer
2011
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
2007
Novel agents and incremental advances in the treatment of head and neck cancer
2004
Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer
2010
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines
2003
Intratumoral forkhead box P3‐positive regulatory T cells predict poor survival in cyclooxygenase‐2–positive uveal melanoma
2010
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
2008
Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA
2000 Nature
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
EMT: 2016
2016 Standout
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
2009
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Gastric cancer
2020 Standout
FOXP3+ Cell Density in Primary Tumor Has No Prognostic Impact in Patients with Cutaneous Malignant Melanoma
2010
Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma
2007
Laryngeal preservation in head and neck cancer: multidisciplinary approach
2006
Prospects for MEK inhibitors for treating cancer
2014
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Natural immunity to cancer in humans
2010
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The treatment of early laryngeal cancers (T1–T2 N0): surgery or irradiation?
2004
Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes
2003
Altered Fractionation and/or Adjuvant Chemotherapy in Definitive Irradiation of Squamous Cell Carcinoma of the Head and Neck
2003
Head and Neck Cancer
2001 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Pancreatic cancer
2011 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
2006
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
Head and Neck Cancer
2020 Standout
Regulatory T Cells and Human Disease
2020 StandoutNobel
Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck
1986
A Unique Subset of CD4+CD25highFoxp3+ T Cells Secreting Interleukin-10 and Transforming Growth Factor-β1 Mediates Suppression in the Tumor Microenvironment
2007
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
2008
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Early Detection of Head and Neck Cancer: Development of a Novel Screening Tool Using Multiplexed Immunobead-Based Biomarker Profiling
2007
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
2008
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
T1-T2N0 Squamous Cell Carcinoma of the Glottic Larynx Treated With Radiation Therapy
2001
Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas
2008
Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions
2006
Epigenetic Down-Regulation of CDKN1C/p57KIP2 in Pancreatic Ductal Neoplasms Identified by Gene Expression Profiling
2005
Immune Regulation of Cancer
2010
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma
2006
Neoantigens in cancer immunotherapy
2015 StandoutScience
Does Histologic Grade Have a Role in the Management of Head and Neck Cancers?
2001
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
2007
Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer
1991 Standout
Exploiting the curative potential of adoptive T‐cell therapy for cancer
2013
Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma.
2000
High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients
2009
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.
2003
Works of Daniel Brasnu being referenced
Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
2006
The Soluble α Chain of Interleukin-15 Receptor: A Proinflammatory Molecule Associated with Tumor Progression in Head and Neck Cancer
2008
Supracricoid Partial Laryngectomy After Failed Laryngeal Radiation Therapy
1996
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours
2013
Adenocarcinoma of the Ethmoid sinuses
1989
Silent gastroesophageal reflux disease in patients with pharyngolaryngeal cancer: Further results
1998
Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma
1999
A Head and Neck Cancer Tumor Response-Specific Gene Signature for Cisplatin, 5-Fluorouracil Induction Chemotherapy Fails with Added Taxanes
2012
Supracricoid laryngectomy with cricohyoidopexy: A partial laryngeal procedure for selected supraglottic and transglottic carcinomas
1990
Cisplatin-Based Neoadjuvant Chemotherapy and Combined Resection for Ethmoid Sinus Adenocarcinoma Reaching and/or Invading the Skull Base
1996
Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3–T4: 5-year oncologic results
1998
Early-Stage Glottic Cancer
2006
Frey's Syndrome Analysis With Biosensor: A Preliminary Study
1993
Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
1996
Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma
2002
Local Control After Supracricoid Partial Laryngectomy for "Advanced" Endolaryngeal Squamous Cell Carcinoma Classified as T3
2004
Laryngofissure and Cordectomy for Glottic Carcinoma Limited to the Mid Third of the Mobile True Vocal Cord
1997
Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for “early” glottic carcinoma classified as T1-T2N0 invading the anterior commissure
1997
Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula
2008
Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders
2001
Transoral Lateral Oropharyngectomy for Squamous Cell Carcinoma of the Tonsillar Region
2005
A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis
1999
Cricohyoidoepiglottopexy for Glottic Carcinoma with Fixation or Impaired Motion of the True Vocal Cord: 5-Year Oncologic Results with 112 Patients
1997
[Induction chemotherapy of cancers of the upper respiratory and digestive tract. Analysis of tumor response in 176 patients].
1985
Vertical Partial Laryngectomy: A Critical Analysis of Local Recurrence
1991
Complications of Postoperative Radiation Therapy after Partial Laryngectomy in Supraglottic Cancer: A Long‐Term Evaluation
2000
[Contribution of L lactate and amino-acid enzymatic biosensors for the analysis of Frey syndrome].
1994
Supracricoid Laryngectomy with Cricohyoidoepiglottopexy: A Partial Laryngeal Procedure for Glottic Carcinoma
1990
Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
2004
Local Failure After Supracricoid Partial Laryngectomy: Symptoms, Management, and Outcome
1998
p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series
2000
Complications of postoperative radiation therapy after partial laryngectomy in supraglottic cancer: A long‐term evaluation
2000
Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
2000
Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer
1999
[Mobility of the vocal cord and the arytenoid in cancer of the larynx and the hypopharynx. Anatomo-clinical study].
1988
Functional Outcome and Prognosis Factors after Supracricoid Partial Laryngectomy with Cricohyoidopexy
1997